Lynx1 Capital Management LP - 21 Oct 2025 Form 3 Insider Report for Neuphoria Therapeutics Inc. (NEUP)

Role
10%+ Owner
Signature
Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member
Issuer symbol
NEUP
Transactions as of
21 Oct 2025
Net transactions value
$0
Form type
3
Filing time
23 Oct 2025, 19:47:16 UTC
Previous filing
21 Oct 2025
Next filing
30 Oct 2025

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Lynx1 Capital Management LP 10%+ Owner D81 CALLE C, STE 301, PMB 1202, DORADO, PUERTO RICO Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member 23 Oct 2025 0001910456
Nichols Weston 10%+ Owner D81 CALLE C, STE 301, PMB 1202, DORADO, PUERTO RICO /s/ Weston Nichols 23 Oct 2025 0001746376

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEUP Common stock, $0.00001 par value per share 236,218 21 Oct 2025 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.